# FDA Inspection 1271552 - Contipro a.s. - February 15, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/contipro-as/882f9b1b-e0b2-4094-8641-9cd10ff4cb69
Source feed: FDA_Inspections

> FDA Inspection 1271552 for Contipro a.s. on February 15, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271552
- Company Name: Contipro a.s.
- Inspection Date: 2024-02-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1058965 - 2018-05-25](https://www.globalkeysolutions.net/records/fda_inspections/contipro-as/95e43348-ae0f-4dec-bebc-db7834424e1a)
- [FDA Inspection 805846 - 2012-10-05](https://www.globalkeysolutions.net/records/fda_inspections/contipro-as/71b2e5dd-fdc8-408a-81bd-c7a1434eee84)

Company: https://www.globalkeysolutions.net/companies/contipro-as/db85d0e1-6272-40fe-9a2b-2491541163f1

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c